R. Gibbins

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care

A. Ford, F. Bishop, R. Foy, 2019, Trials.

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, Shruti Singh, 2020, The Lancet.

Neural reorganisation in porcine vein grafts: a potential role for endothelin-1.

G. Angelini, M. Dashwood, J. Jeremy, 2000, Atherosclerosis.

Sacral chordoma: a diagnosis not to be sat on?

R. Grimer, L. Jeys, G. Evans, 2008, International Orthopaedics.

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, L. Lovat, 2020, The Lancet.